Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Artificial Intelligence topic
No spam. Unsubscribe anytime.
Committee debates neurological rights, definitions and role of AI advisory council in health and human services bill
Summary
Witnesses including the Attorney General's Office and legislative counsel urged caution before enshrining broad neurological rights; the committee directed the AI advisory council and relevant agencies to clarify definitions, study HIPAA interactions and report back with recommendations.
The Senate Health & Welfare Committee took testimony April 16 on a bill that would recognize neurological rights and expand the state’s artificial intelligence advisory council’s membership and charge.
Todd Davis, assistant attorney general and director of policy and legislative affairs at the Attorney General’s Office, told the committee the AG’s consumer protection work focuses on AI‑related privacy and fraud risks. "We see AI as a major danger to the scam world," Davis said, noting the office sits on the existing AI advisory council and that litigation has been brought where the AG believes AI was being used fraudulently or deceptively.
Legislative counsel and committee members reviewed the bill’s four parts: legislative intent and protections for neurological rights (section one and two); changes to AI advisory council membership and an extension of its sunset (section three); and a directive for the council to consult stakeholders and report on AI use in health, education and public finance (section four). Counsel explained the bill would codify a chapter recognizing certain neurologic data privacy and "freedom of thought" protections but that, as drafted, those rights are largely aspirational and presently lack an enforcement mechanism.
Committee members and witnesses raised two recurring concerns. First, several participants asked how broadly worded neurological rights would intersect with existing medical privacy law and regulation (HIPAA). A speaker identified in the transcript as "Jess" said the bill’s current language may be unclear about whether it covers consumer neurotechnology outside regulated medical contexts and suggested the AI advisory council study how other jurisdictions are addressing the issue before the Legislature adopts enforceable statutory rights.
Second, members emphasized the need for consistent technical definitions across bills — for example, "artificial intelligence system," "generative AI" and "augmented intelligence" — and recommended coordination with the Agency of Digital Services, which already maintains a statutory definition for AI systems in the executive branch context.
Committee members indicated they are likely to send some sections to the appropriate committees for further work and to ask the AI advisory council, in coordination with the director of the Division of Artificial Intelligence and other stakeholders, to develop definitions, guidance and recommendations for statutory or regulatory changes. No final vote or enactment occurred during the hearing.
Provenance: Testimony and discussion on neurological rights and AI advisory council began with the bill introduction (SEG 657) and continued through counsel and stakeholder exchanges (topic end SEG 1379).
